RTP’s Locus Biosciences closes $35M Series B, investors include J&J and Tencent
Locus Biosciences, which is managing partnerships worth more than $1 billion, announced this morning it had closed a Series B fundraising round.
Read More
Paul Garofolo
Locus Biosciences raises $10.5M in equity, more funding coming
Locus Biosciences has raised more than $10.5 million in equity from three investors, according to an SEC filing, and the company could some $9 million more.
Read More
Gene editing success could turn Triangle startup Locus Biosciences into a billion dollar unicorn
Locus Biosciences has inked nearly $1 billion in deals to develop its gene-editing and bacteriophage technology that could combat antibiotic resistance and which targets specific bad bacteria, leaving good bacteria unharmed. Here’s the story, exclusively for TechWire readers.
Read More
